JUN and myeloproliferative neoplasm: In summary, NT157 exerts antineoplastic effects in JAK2V617F-positive cells by targeting many mechanisms, downregulating IRS1/2, JAK2/STAT, NFκB signaling, and activating the AP-1 complex in MPN.